Text Size
1261 studies found for:    "Hepatitis C"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Completed Study of ABT-267 in Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Infected Subjects
Conditions: Chronic Hepatitis C;   Hepatitis C Virus (HCV)
Interventions: Drug: ABT-267;   Drug: Peginterferon alpha-2a (pegIFN);   Drug: Ribavirin (RBV);   Drug: Placebo
22 Completed A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ABT-450 With Ritonavir (ABT-450/r) Dosed in Combination With ABT-072 and Ribavirin (RBV)
Conditions: Hepatitis C;   HCV;   Chronic Hepatitis C;   Hepatitis C Genotype 1
Interventions: Drug: ABT-450/r;   Drug: ABT-072;   Drug: ribavirin
23 Completed SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C
Conditions: Hepatitis C, Chronic;   Hepatitis C;   Thrombocytopenia
Interventions: Drug: SB497115;   Other: Placebo
24 Completed Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin
Conditions: Hepatitis C;   Hepatitis C, Chronic
Interventions: Drug: thymalfasin (thymosin alpha 1);   Drug: PEGinterferon alfa-2a
25 Completed Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin
Conditions: Hepatitis C;   Hepatitis C, Chronic
Interventions: Drug: thymalfasin (thymosin alpha 1) + PEGinterferon alfa-2a;   Drug: placebo + PEGinterferon alfa-2a
26 Unknown † HDV-Interferon in the Treatment of Chronic Hepatitis C Nonresponders and Naive Hepatitis C Patients
Condition: Chronic Hepatitis C
Interventions: Drug: Oral HDV-Interferon + ribavarin;   Drug: Injectable HDV-Interferon + ribavarin
27 Active, not recruiting Study of DEB025/Alisporivir Plus Pegylated Interferon alfa2a and Ribavirin and Boceprevir Plus Pegylated Interferon alfa2a and Ribavirin in African American Chronic Hepatitis C Genotype 1 Patients That Have Never Received Treatment for Their Hepatitis C
Conditions: Hepatitis C;   Liver Disease
Interventions: Drug: DEB025 plus peg-IFN alpha 2a and ribavirin fixed duration treatment;   Drug: DEB025 plus peg-IFN alpha 2a and ribavirin response guided treatment duration;   Drug: Boceprevir plus peg-IFN alpha 2a and ribavirin per label response guided treatment
28 Unknown † Fatty Liver in Chronic Hepatitis C (HCV): Is There a Difference in Oxidative Stress and Inflammation Compared to HCV Without Fatty Liver?
Conditions: Hepatitis C;   Steatosis or no Steatosis
Intervention:
29 Active, not recruiting An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1)
Condition: Chronic Hepatitis C
Interventions: Drug: Telaprevir;   Drug: Ribavirin;   Drug: Pegylated-Interferon-alfa-2a
30 Completed Safety and Efficacy of the Therapeutic Vaccine GI-5005 Versus Placebo for the Treatment of Chronic Hepatitis C Infection
Condition: Hepatitis C
Intervention: Biological: GI-5005
31 Completed
Has Results 		Observational Study Assessing Chronic Hepatitis C Management in Clinical Practice in Italy (Study P05488 AM1)
Conditions: Hepatitis C;   Hepatitis C, Chronic
Interventions: Biological: Peginterferon alfa-2b;   Drug: Ribavirin;   Biological: Peginterferon alfa-2a
32 Completed Efficacy of Pegetron® Redipen™ Treatment and Treatment Compliance of Patients With Chronic Hepatitis C in Canada (P04423 AM4)
Conditions: Hepatitis C, Chronic;   Hepatitis C
Interventions: Biological: Peginterferon alfa-2b;   Drug: Ribavirin
33 Withdrawn An Observational Study of Patients With Chronic Hepatitis C Undergoing Treatment With PegIntron and Rebetol in Clinical Practice in Belgium (Study P05494)(WITHDRAWN)
Conditions: Hepatitis C, Chronic;   Hepatitis C
Interventions: Biological: PegIntron (peginterferon alfa-2b; SCH 54031);   Drug: Rebetol (ribavirin; SCH 18908)
34 Completed
Has Results 		Efficacy of PegIntron (Peginterferon Alfa-2b) and Rebetol (Ribavirin) in Treatment-naïve Subjects With Chronic Hepatitis C in Clinical Practice in Greece (Study P05209)
Conditions: Hepatitis C, Chronic;   Hepatitis C
Interventions: Biological: PegIntron (peginterferon alfa-2b, pegylated interferon alfa-2b);   Drug: Rebetol (ribavirin)
35 Terminated Viral Kinetic Study With Viramidine in Therapy-Naive Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Drug: Viramidine;   Drug: Peginterferon alfa-2b
36 Completed Peginterferon and Ribavirin on Virologic and Immunologic Parameters in Hepatitis C Mono- and Coinfected Patient (PRIVICOP)
Conditions: Hepatitis C;   HIV Infections
Intervention: Procedure: venous blood puncture
37 Unknown † Increasing Cure Rate of Hepatitis C Therapy in Obese Hepatitis C Patients
Conditions: Obesity;   Insulin Resistance;   Metabolic Syndrome;   Hepatitis C
Interventions: Drug: Orlistat;   Behavioral: Dietary and Lifestyle modification educational sessions
38 Completed Induction Dosing With Pegylated Interferon Alfa 2a and Ribavirin in Patients With Chronic Hepatitis C Genotype 1
Condition: Chronic Hepatitis C
Interventions: Drug: high dose peg-ifn plus rbv;   Drug: standard peg-ifn plus ribavirin
39 Completed A Clinical Research Study Designed To Determine If Treatment of Hepatitis C With Milk Thistle is More Effective Than No Treatment In Patients Infected With Both HIV And Hepatitis C
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: Silymarin;   Drug: Placebo
40 Completed A Randomized Study to Evaluate the Safety, Tolerability and Antiviral Activity of ABT-450, ABT-333 and ABT-072
Conditions: Hepatitis C;   HCV;   Chronic Hepatitis C;   Genotype 1
Interventions: Drug: ABT-450;   Drug: ABT-072;   Drug: ABT-333;   Drug: ritonavir;   Drug: pegIFN;   Drug: ribavirin;   Other: Placebo
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years